Example: Heart Attack

Clinical Trials on HIV-Associated Lipodystrophy Syndrome

Total 25 results

NCT00383734

Completed

Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE

Conditions: HIV-Associated Lipodystrophy Syndrome
NCT01848340

Completed

An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Conditions: HIV-associated Lipodystrophy Syndrome
NCT01359917

Completed

Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome

Conditions: HIV-Associated Lipodystrophy Syndrome
NCT00646984

Completed

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Conditions: HIV-Associated Lipodystrophy Syndrome
NCT00135460

Unknown status

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients

Conditions: HIV-Associated Lipodystrophy Syndrome
NCT00135356

Completed

Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Conditions: HIV-Associated Lipodystrophy Syndrome
NCT00122226

Unknown status

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

Conditions: HIV Infections; HIV-Associated Lipodystrophy Syndrome
NCT00662181

Unknown status

Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

Conditions: HIV Infections; HIV-Associated Lipodystrophy Syndrome
NCT00148850

Terminated

Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients

Conditions: HIV-Associated Lipodystrophy Syndrome; HIV Infections
NCT00122668

Terminated

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Conditions: HIV Infections; HIV-Associated Lipodystrophy Syndrome
NCT00192660

Completed

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Conditions: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease
NCT01511016

Completed

Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome

Conditions: HIV Lipodystrophy
NCT00122655

Terminated

Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy

Conditions: HIV Infections; HIV Lipodystrophy Syndrome
NCT00126308

Terminated

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

Conditions: HIV-Associated Lipodystrophy; HIV Infections
NCT03226821

Recruiting

Body Composition and Adipose Tissue in HIV

Conditions: HIV Lipodystrophy Syndrome; Growth Hormone Deficiency; Body Composition
NCT02530827

Completed

Energy Expenditure of People Living With HIV/AIDS

Conditions: HIV/AIDS; HIV Lipodystrophy Syndrome
NCT00139178

Completed

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Conditions: HIV Associated Lipodystrophy Syndrome.; HIV; Hypercholesterolemia; Lipoatrophy
NCT00130286

Completed

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Conditions: HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; HIV Infections; Metabolic Syndrome X; Body Weight Changes
NCT00069004

Completed

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Conditions: HIV Infections; HIV-Associated Lipodystrophy Syndrome; HIV Lipodystrophy Syndrome; Lipodystrophy; Dyslipidemia; Osteoporosis; Osteopenia
NCT03075332

Completed

Detraining in People Living With HIV/AIDS

Conditions: Lipodystrophy Syndrome, HIV; Sarcopenia
NCT00608023

Completed

TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy

Conditions: Lipodystrophy; HIV Infections
NCT00123253

Completed

TH9507 in Patients With HIV-Associated Lipodystrophy

Conditions: HIV Infections; Lipodystrophy
NCT04340388

Recruiting

Contribution of Dolutegravir to Obesity and Cardiovascular Disease

Conditions: HIV-1-infection; Antiviral Drug Adverse Reaction; Vascular Diseases; Cardiovascular Abnormalities; Abnormality of Adipose Tissue; Body Weight Changes; Body Fat Disorder; HIV-Associated Lipodystrophy Syndrome
NCT01077765

Completed

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

Conditions: HIV Infection; Antiretroviral Side Effects; Lipodystrophy Syndrome Related to HIV Infection
NCT00461552

Completed

Therapeutic Approaches to HAART-Induced Lipodystrophy

Conditions: HIV Infections; Lipodystrophy